Financhill
Sell
13

GLYC Quote, Financials, Valuation and Earnings

Last price:
$0.21
Seasonality move :
-6.72%
Day range:
$0.21 - $0.24
52-week range:
$0.14 - $3.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.23x
Volume:
321.4K
Avg. volume:
1.3M
1-year change:
-91.48%
Market cap:
$14M
Revenue:
$10K
EPS (TTM):
-$0.62

Earnings Data

Next earnings date for GLYC
Mar 27
2025
Most recent earnings per share
-$0.15
Missed by $0.15
(Nov 13/2024)
Consensus Estimate
--
(Nov 13/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GLYC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/27/2025 Q4 -- -- -- -- --
11/13/2024 Q3 -- -- -$0.15 -- --
08/08/2024 Q2 -- -- -$0.16 -$0.15 -$0.01
05/09/2024 Q1 -- -- -$0.17 -$0.16 -$0.01
03/27/2024 Q4 -- $10K -$0.14 -$0.15 $0.01
11/03/2023 Q3 -- -- -$0.14 -$0.14 --
08/02/2023 Q2 -- -- -$0.13 -$0.17 $0.04
05/03/2023 Q1 -- -- -$0.17 -$0.17 -$0.01
03/29/2023 Q4 -- -- -$0.19 -$0.17 -$0.03
11/09/2022 Q3 -- -- -$0.16 -$0.25 $0.09
08/03/2022 Q2 -- -- -$0.25 -$0.28 $0.03
04/28/2022 Q1 -- -- -$0.28 -$0.32 $0.04
03/03/2022 Q4 -- -- -$0.33 -$0.34 $0.01
11/02/2021 Q3 -- -- -$0.34 -$0.32 -$0.02
08/05/2021 Q2 -- -- -$0.28 -$0.31 $0.03
05/03/2021 Q1 -- -- -$0.28 -$0.32 $0.04
03/02/2021 Q4 -- -- -$0.32 -$0.32 $0.00
11/06/2020 Q3 -- -- -$0.29 -$0.32 $0.03
07/31/2020 Q2 -- -- -$0.32 -$0.37 $0.05
05/01/2020 Q1 -- -- -$0.18 -$0.29 $0.11
02/28/2020 Q4 -- -- -$0.34 -$0.35 $0.01
11/07/2019 Q3 -- -- -$0.31 -$0.41 $0.10
08/01/2019 Q2 -- -- -$0.37 -$0.37 --
05/02/2019 Q1 -- -- -$0.33 -$0.36 $0.03
03/06/2019 Q4 -- -- -$0.32 -$0.31 -$0.01
11/02/2018 Q3 -- -- -$0.27 -$0.32 $0.05
08/09/2018 Q2 -- -- -$0.26 -$0.34 $0.08
05/03/2018 Q1 -- -- -$0.33 -$0.28 -$0.05
03/06/2018 Q4 -- -- -$0.27 -$0.25 -$0.02
11/08/2017 Q3 -- -- -$0.24 -$0.30 $0.06
06/30/2017 Q2 -- -- -$0.30 -$0.35 $0.05
05/03/2017 Q1 -- -- -$0.34 -$0.36 $0.02
03/01/2017 Q4 -- -- -$0.36 -$0.36 --
11/04/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
05/03/2016 Q1 -- -- -- -- --
03/21/2016 Q4 -- -- -- -- --
11/13/2015 Q3 -- -- -- -- --
08/13/2015 Q2 -- -- $0.51 -- --
05/14/2015 Q1 -- -- -- -- --
03/30/2015 Q4 -- -- -- -- --

GlycoMimetics Earnings Questions

  • How Much did GlycoMimetics Generate in Revenue Last Quarter?

    GlycoMimetics reported -- worth of top line sales in its most recent quarter.

  • Did GlycoMimetics Beat Earnings Last Quarter?

    GlycoMimetics announced earnings per share of -$0.15 which represents a miss of analyst forecast a -- per share.

  • Is GlycoMimetics Profitable?

    GlycoMimetics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for GlycoMimetics EPS Next Year?

    GlycoMimetics's earnings are forecast to decrease from -$0.58 per share to -$0.61 per share next year representing a decrease of -12.07%.

  • When is GlycoMimetics's Earnings Date?

    GlycoMimetics's next earnings date is March 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is down 8.7% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 9.77% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is up 7.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock